LVTX
vs
S&P 500
LVTX
S&P 500
Over the past 12 months, LVTX has outperformed S&P 500, delivering a return of +37% compared to the S&P 500's +18% growth.
Stocks Performance
LVTX vs S&P 500
Performance Gap
LVTX vs S&P 500
Performance By Year
LVTX vs S&P 500
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
LAVA Therapeutics NV
Glance View
LAVA Therapeutics NV operates as a biotechnology company, which develops immune oncology biopharmaceutical products. The company is headquartered in Utrecht, Utrecht and currently employs 55 full-time employees. The firm focuses of developing next generation Vdelta T cell engaging bispecific antibodies to fight cancer.